RhumbLine Advisers’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $408K | Sell |
27,048
-327
| -1% | -$4.93K | ﹤0.01% | 2810 |
|
|
2025
Q1 | $440K | Buy |
27,375
+1,614
| +6% | +$26K | ﹤0.01% | 2653 |
|
|
2024
Q4 | $448K | Buy |
25,761
+9
| +0% | +$157 | ﹤0.01% | 2743 |
|
|
2024
Q3 | $452K | Buy |
25,752
+23
| +0.1% | +$403 | ﹤0.01% | 2764 |
|
|
2024
Q2 | $288K | Buy |
25,729
+1,608
| +7% | +$18K | ﹤0.01% | 3024 |
|
|
2024
Q1 | $210K | Buy |
24,121
+724
| +3% | +$6.31K | ﹤0.01% | 3152 |
|
|
2023
Q4 | $286K | Buy |
23,397
+5,660
| +32% | +$69.3K | ﹤0.01% | 3000 |
|
|
2023
Q3 | $71.5K | Buy |
17,737
+1,952
| +12% | +$7.87K | ﹤0.01% | 3564 |
|
|
2023
Q2 | $113K | Buy |
+15,785
| New | +$113K | ﹤0.01% | 3473 |
|
|
2022
Q2 | – | Sell |
-13,340
| Closed | -$65K | – | 3203 |
|
|
2022
Q1 | $65K | Sell |
13,340
-301
| -2% | -$1.47K | ﹤0.01% | 2953 |
|
|
2021
Q4 | $202K | Sell |
13,641
-252
| -2% | -$3.73K | ﹤0.01% | 2832 |
|
|
2021
Q3 | $300K | Buy |
13,893
+593
| +4% | +$12.8K | ﹤0.01% | 2766 |
|
|
2021
Q2 | $218K | Sell |
13,300
-1,087
| -8% | -$17.8K | ﹤0.01% | 2904 |
|
|
2021
Q1 | $341K | Sell |
14,387
-1,140
| -7% | -$27K | ﹤0.01% | 2655 |
|
|
2020
Q4 | $370K | Buy |
15,527
+975
| +7% | +$23.2K | ﹤0.01% | 2572 |
|
|
2020
Q3 | $172K | Sell |
14,552
-2,360
| -14% | -$27.9K | ﹤0.01% | 2733 |
|
|
2020
Q2 | $177K | Buy |
16,912
+2,515
| +17% | +$26.3K | ﹤0.01% | 2810 |
|
|
2020
Q1 | $103K | Hold |
14,397
| – | – | ﹤0.01% | 2772 |
|
|
2019
Q4 | $193K | Buy |
14,397
+68
| +0.5% | +$912 | ﹤0.01% | 2760 |
|
|
2019
Q3 | $221K | Sell |
14,329
-105
| -0.7% | -$1.62K | ﹤0.01% | 2713 |
|
|
2019
Q2 | $191K | Buy |
14,434
+875
| +6% | +$11.6K | ﹤0.01% | 2797 |
|
|
2019
Q1 | $239K | Sell |
13,559
-358
| -3% | -$6.31K | ﹤0.01% | 2668 |
|
|
2018
Q4 | $159K | Buy |
+13,917
| New | +$159K | ﹤0.01% | 2798 |
|
|
2017
Q3 | – | Sell |
-9,415
| Closed | -$325K | – | 2904 |
|
|
2017
Q2 | $325K | Buy |
+9,415
| New | +$325K | ﹤0.01% | 2517 |
|